Emodin Interferes With AKT1-Mediated DNA Damage and Decreases Resistance of Breast Cancer Cells to Doxorubicin

Li, B; Zhao, X; Zhang, L; Cheng, W

Cheng, W (corresponding author), Harbin Med Univ, Canc Hosp, Dept Ultrasound, Harbin, Peoples R China.

FRONTIERS IN ONCOLOGY, 2021; 10 ():

Abstract

Doxorubicin (DOX) is a cytotoxic drug used for the treatment of breast cancer (BC). However, the rapid emergence of resistance toward doxorubicin thre......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索